Scaling Personalized Medicine: The Complex Industrialization of CAR-T Therapy for Global Access
admin At the Raritan, New Jersey, facility, a poignant encounter unfolded where Colleen, a multiple myeloma...
biotech
A Promise Made, A Promise Kept: Meet the Inaugural CRI IGNITE Fellows
Announced in October 2025, the IGNITE Award – an acronym for Inspiring Growth and Nurturing...
Teva claims success in celiac study; BioMarin, Ascendis settle patent dispute
The biopharmaceutical industry has seen a flurry of significant developments, including promising clinical trial results,...
July: A Critical Juncture for Ultraviolet Radiation Safety Awareness and Skin Cancer Prevention
July marks Ultraviolet (UV) Radiation Safety Awareness Month, an annual observance dedicated to highlighting the...
UniQure Navigates Tumultuous FDA Path for Huntington’s Gene Therapy, Seeking Approval Amidst Regulatory Shifts
UniQure, a leading gene therapy company, is currently awaiting a pivotal decision from the U.S....
Setbacks Emerge for Pioneering CAR-T Therapies in Autoimmune Diseases as Clinical Trials Face Safety Pauses
The promising frontier of harnessing powerful CAR-T cell therapies, long lauded for their transformative impact...
ESC Congress Unveils Pivotal Cardiovascular Trial Data, Reshaping Treatment Paradigms and Market Dynamics
The annual congress of the European Society of Cardiology (ESC), a preeminent global event in...
Alumis’s Envudeucitinib Fails to Meet Primary Endpoints in Phase 2b Lupus Trial, Shares Plunge Amid Broader TYK2 Inhibitor Challenges
Alumis, a biopharmaceutical company focused on precision immunology, faced a significant setback on September 1,...
Novartis’s Remibrutinib Emerges as a Differentiated BTK Inhibitor, Evading Liver Safety Concerns Plaguing Rivals in the Autoimmune Landscape
Novartis has announced a significant breakthrough in the development of its investigational Bruton’s Tyrosine Kinase...
Mid-cap biotechs join Trump’s latest round of drug pricing deals
In a significant development for the U.S. pharmaceutical landscape, the Trump administration on Monday announced...
